This research demonstrates improved power conversion efficiency in Pb-Sn perovskite solar cells, highlighting how benzamidine aids crystallinity and oxidation stability.
Mixed Pb–Sn perovskite has attracted considerable attention owing to its lower toxicity and broader light absorption range than pure Pb-based perovskite. However, easy oxidation of Sn2+ into Sn4+ and uncontrollable crystallization of the Pb–Sn perovskite severely limit efficiency and stability of Pb–Sn perovskite solar cells (PSCs). Herein, a benzamidine derivative 4-aminobenzamidine dihydrochloride (4-ABD) was employed as a multifunctional additive in the Pb–Sn perovskite layer, as it simultaneously improved crystallinity, inhibited the oxidation of Sn2+, stabilized the crystal structure, and passivated defects. As a result, a power conversion efficiency of 22.33% with excellent operational stability has been achieved because the incorporation of 4-ABD not only accelerated carrier transport and extraction but also suppressed carrier recombination in the Pb–Sn PSCs. Moreover, the 4-ABD-modified Pb–Sn PSCs performed excellent thermal stability and storage stability. This work provides a promising, effective strategy for achieving high-efficiency, stable Pb–Sn PSCs.
No takes yet. Share an insight, caveat, or question.
Bing et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: